New Clostridioides difficile vaccine on the horizon • healthcare-in-europe.com
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile | BMC Infectious Diseases | Full Text
A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection | Infectious Diseases and Therapy
Cytotoxic activity of purified toxins from prevalent C. difficile... | Download Table
New Research Tests C. Difficile Vaccine Efficacy - Drexel University College of Medicine
Pfizer's seeks silver lining in failed C. diff vaccine trial | pharmaphorum
Frontiers | Host Immune Responses to Clostridioides difficile: Toxins and Beyond
Percentages of participants who achieved prespecified levels of toxin... | Download Scientific Diagram
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
Synthetic Oligosaccharide-Based Vaccines Protect Mice from Clostridioides difficile Infections | ACS Chemical Biology
C. difficile pipeline vaccines could offer an alternative to antibiotics - Clinical Trials Arena
In silico designing of vaccine candidate against Clostridium difficile | Scientific Reports
Frontiers | Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile
C. Diff Vaccine (high risk patients) – J. Lewis Research, Inc.
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial - The Lancet Infectious Diseases
Immunology and Clostridium difficile | Clostridium difficile: New Challenges for an Old Foe
Old C. difficile Vaccine Candidate MVX02 | matrivax
Pathogens | Free Full-Text | Non-Toxin-Based Clostridioides difficile Vaccination Approaches
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection | NEJM
Emerging Vaccines for Clostridium difficile Infection Treatment
View PDF
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes | NEJM
Pfizer's C. Difficile Vaccine Misses Primary Endpoint in Trial
Frontiers | Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection
